Trial | NCT00913224  Report issue

Title

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets
A Relative Bioavailability Study of Diclofenac Sodium 50 mg Enteric-Coated Tablets

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    diclofenac ...

  • Study Participants

    38
To demonstrate the relative bioavailability of Diclofenac Sodium 50 mg enteric-coated tablets.
Study Started
Apr 30
1993
Primary Completion
Apr 30
1993
Study Completion
Apr 30
1993
Last Update
Mar 28
2017

Drug Diclofenac Sodium 50 mg Tablets (Geneva Pharmaceuticals, Inc)

Drug Voltaren 50 mg Tablets (Geigy Pharmaceuticals)

1 Experimental

Diclofenac Sodium 50 mg Tablets (Geneva Pharmaceuticals, Inc)

2 Active Comparator

Voltaren 50 mg Tablets (Geigy Pharmaceuticals)

Criteria 

Inclusion Criteria:

No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

Exclusion Criteria:

Positive test results for HIV or hepatitis B or C.
Treatment for drug or alcohol dependence.
No Results Posted